[LDH determination to control therapy of gynecologic cancer].
D000230:Adenocarcinoma / Q000097:blood / Q000201:enzymology* / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000201:enzymology* / Q000532:radiotherapy; D004796:Clinical Enzyme Tests; D003036:Cobalt Isotopes / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000201:enzymology* / Q000532:radiotherapy; D006049:Gold Isotopes / Q000627:therapeutic use; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008291:Malate Dehydrogenase / Q000097:blood; D011867:Radioisotope Teletherapy; D011883:Radium / Q000627:therapeutic use
D003036:Cobalt Isotopes; D006049:Gold Isotopes; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D011883:Radium
Die LDH-Bestimmung zur Therapiekontrolle gynäkologischer Karzinome.